Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Annals of Clinical and Translational Neurology|December 19, 2023
Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.Brain : a Journal of Neurology|November 8, 2022
Anti-pan-neurofascin antibodies induce subclass-related complement activation and nodo-paranodal damageLuise Appeltshauser, Helena Junghof, Julia Messinger, et al.Multiple Sclerosis and Related Disorders|November 24, 2023
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.BMJ Neurology Open|October 24, 2025
Dyadic Coping of NMOSD and MOGAD patients and their partners: a sociological and psychological examination of strategies (CoMMOnsense-Study)Anna Walz, Daria Tkachenko, Martin W Hümmert, et al.Neurology|December 5, 2019
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disordersMarius Ringelstein, Jens Harmel, Hanna Zimmermann, et al.Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2021
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum DisordersMarius Ringelstein, Ilya Ayzenberg, Gero Lindenblatt, et al.Frontiers in Immunology|April 28, 2025
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)Julian Reza Kretschmer, Daria Tkachenko, Tania Kümpfel, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 12, 2025
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysisAhmed Abdelhak, Franziska Bachhuber, Kiarra Ning, et al.Pageof 3